% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • faosto faosto Oct 18, 2012 3:08 PM Flag

    FDA Panel votes 9-6 in favor of ISIS mipomersen

    ... with one "weak yes vote". FDA will see this almost as an 8-7 vote which is very weak. I predict that the FDA will require additional data on tumor growth and fat buildup. This would have sailed through had there not been AEGR's drug the day before , which has a better safety profile and more efficacy. Any endocrinoligist prescribing a med will choose lomitapide first, Mipo second. Getting FDA approval on Mipo is by no means a slam dunk at this point. AEGR will be at 25 by Monday.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.97-0.09(-2.94%)Sep 30 4:00 PMEDT